Thursday, 8 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Merger & Restructuring

Every merger & restructuring announcement on NSE and BSE that our alert engine sent, newest first.

20:31 IST NSE
Merger & RestructuringOriana Power Ltd ORIANA

Oriana Power Merger & Restructuring Worth ₹0.01 Cr

Oriana Power Limited incorporated SOLAREDGE ENERGY PRIVATE LIMITED as a new step-down subsidiary. The entity focuses on power generation and has ₹0.01 Crore authorized capital.

Value
₹0.01 Cr
19:41 IST NSE
Merger & RestructuringMankind Pharma Ltd MANKIND

Mankind Pharma Merger & Restructuring Worth ₹500 Cr

Mankind Pharma approved a ₹500 Crore investment in its subsidiary, Mankind Medicare, for capacity expansion. The capital will fund a new pharmaceutical manufacturing plant.

Value
₹500.0 Cr
19:21 IST BSE
Merger & RestructuringGujarat Themis Biosyn Ltd GUJTHEM

Gujarat Themis Biosyn Merger & Restructuring Worth ₹0.61 Cr

Gujarat Themis Biosyn incorporated a wholly owned subsidiary in Japan named Themis Biosyn Japan Limited. This expansion strengthens the company's international pharmaceutical business footprint.

Value
₹0.61 Cr
18:58 IST BSE
Merger & RestructuringGabriel India Ltd GABRIEL

Gabriel India Merger & Restructuring

Gabriel India received the certified NCLT order sanctioning its composite scheme of arrangement. The restructuring involves demerging automotive undertakings into the company to streamline operations.

18:48 IST NSE
Merger & RestructuringDhanuka Agritech Ltd DHANUKA

Dhanuka Agritech Merger & Restructuring Worth ₹2 Cr

Dhanuka Agritech approved incorporating two wholly owned subsidiaries in Brazil and Europe with a ₹2 Crore initial investment. These entities will support global brand registrations.

Value
₹2.00 Cr
18:16 IST BSE
Merger & RestructuringAcutaas Chemicals Ltd ACUTAAS

Acutaas Chemicals Merger & Restructuring Worth ₹5.83 Cr

Acutaas Chemicals Ltd subsidiary ACEPL allotted shares worth ₹5.83 Crore to A.R.Z Pharma Ltd. Consequently, ACEPL ceased being wholly-owned, with the parent's stake diluting to 90%.

Value
₹5.83 Cr
16:31 IST NSE
Merger & RestructuringAmbey Laboratories Limited AMBEY

Ambey Laboratories Merger & Restructuring Worth ₹9.1 Cr

Ambey Laboratories approved converting a ₹9.10 Crore inter-company loan into equity shares of its subsidiary. The restructuring strengthens the subsidiary's capital base without fresh cash outflow.

Value
₹9.10 Cr
Execution
within one month